Advent Capital Management Sarepta Therapeutics, Inc. Transaction History
Advent Capital Management
- $155 Million
- Q3 2024
A detailed history of Advent Capital Management transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Advent Capital Management holds 5,000 shares of SRPT stock, worth $552,500. This represents 0.4% of its overall portfolio holdings.
Number of Shares
5,000
Previous 10,000
50.0%
Holding current value
$552,500
Previous $1.58 Million
60.51%
% of portfolio
0.4%
Previous 1.69%
Shares
6 transactions
Others Institutions Holding SRPT
# of Institutions
531Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.14 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$991 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$692 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$482 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$472 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.68B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...